Scynexis (SCYX) Cash & Equivalents (2013 - 2026)
Scynexis (SCYX) recorded Cash & Equivalents of $10.49 million in Q2 2026, down 4.8% from $11.02 million a year earlier and down 71.4% from the prior quarter.
Powered by 
Analysis
Scynexis (SCYX) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Scynexis reported Cash & Equivalents of $21.26 million, up 32.4% from FY2024.
- Annual Cash & Equivalents has a five-year compound annual growth rate of -25.6% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $16.05 million in FY2024 (-52.9%), $34.05 million in FY2023 (-25.7%), $45.81 million in FY2022 (-56.2%) and $104.48 million in FY2021 (+12.3%).
- The Q2 2026 figure is the lowest quarterly Cash & Equivalents since Q1 2025.
- On a year-over-year basis, Cash & Equivalents rose in two of the last eight quarters, with growth averaging 22.7%.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 428.2% in Q1 2026, against a decline of 80.4% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $36.67 million (Q1 2026), $21.26 million (Q4 2025) and $14.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Scynexis | 50.94 Mn | -20.16 Mn | - | 10.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.49 Mn |
| Mar 31, 2026 | 36.67 Mn |
| Dec 31, 2025 | 21.26 Mn |
| Sep 30, 2025 | 14.80 Mn |
| Jun 30, 2025 | 11.02 Mn |
| Mar 31, 2025 | 6.94 Mn |
| Dec 31, 2024 | 16.05 Mn |
| Sep 30, 2024 | 28.73 Mn |
| Jun 30, 2024 | 25.99 Mn |
| Mar 31, 2024 | 35.48 Mn |
| Dec 31, 2023 | 34.05 Mn |
| Sep 30, 2023 | 44.07 Mn |
| Jun 30, 2023 | 57.91 Mn |
| Mar 31, 2023 | 26.91 Mn |
| Dec 31, 2022 | 45.81 Mn |
| Sep 30, 2022 | 68.62 Mn |
| Jun 30, 2022 | 118.70 Mn |
| Mar 31, 2022 | 95.21 Mn |
| Dec 31, 2021 | 104.48 Mn |
| Sep 30, 2021 | 100.11 Mn |
API Access
Scynexis Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SCYX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SCYX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SCYX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();